These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11751905)

  • 1. Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.
    Podar K; Tai YT; Lin BK; Narsimhan RP; Sattler M; Kijima T; Salgia R; Gupta D; Chauhan D; Anderson KC
    J Biol Chem; 2002 Mar; 277(10):7875-81. PubMed ID: 11751905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways.
    Suzuma I; Suzuma K; Ueki K; Hata Y; Feener EP; King GL; Aiello LP
    J Biol Chem; 2002 Jan; 277(2):1047-57. PubMed ID: 11694503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signaling.
    Tai YT; Podar K; Catley L; Tseng YH; Akiyama M; Shringarpure R; Burger R; Hideshima T; Chauhan D; Mitsiades N; Richardson P; Munshi NC; Kahn CR; Mitsiades C; Anderson KC
    Cancer Res; 2003 Sep; 63(18):5850-8. PubMed ID: 14522909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity.
    Wijelath ES; Murray J; Rahman S; Patel Y; Ishida A; Strand K; Aziz S; Cardona C; Hammond WP; Savidge GF; Rafii S; Sobel M
    Circ Res; 2002 Jul; 91(1):25-31. PubMed ID: 12114318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.
    Xia P; Aiello LP; Ishii H; Jiang ZY; Park DJ; Robinson GS; Takagi H; Newsome WP; Jirousek MR; King GL
    J Clin Invest; 1996 Nov; 98(9):2018-26. PubMed ID: 8903320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.
    Gille H; Kowalski J; Yu L; Chen H; Pisabarro MT; Davis-Smyth T; Ferrara N
    EMBO J; 2000 Aug; 19(15):4064-73. PubMed ID: 10921887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding.
    Yu Y; Hulmes JD; Herley MT; Whitney RG; Crabb JW; Sato JD
    Biochem J; 2001 Sep; 358(Pt 2):465-72. PubMed ID: 11513746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.
    Gille H; Kowalski J; Li B; LeCouter J; Moffat B; Zioncheck TF; Pelletier N; Ferrara N
    J Biol Chem; 2001 Feb; 276(5):3222-30. PubMed ID: 11058584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation.
    Wu LW; Mayo LD; Dunbar JD; Kessler KM; Baerwald MR; Jaffe EA; Wang D; Warren RS; Donner DB
    J Biol Chem; 2000 Feb; 275(7):5096-103. PubMed ID: 10671553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways.
    Zeng H; Dvorak HF; Mukhopadhyay D
    J Biol Chem; 2001 Jul; 276(29):26969-79. PubMed ID: 11350975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3'-kinase-mediates PKC delta phosphorylation: role of PKC in angiogenesis.
    Gliki G; Wheeler-Jones C; Zachary I
    Cell Biol Int; 2002; 26(9):751-9. PubMed ID: 12377207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells.
    Gratton JP; Morales-Ruiz M; Kureishi Y; Fulton D; Walsh K; Sessa WC
    J Biol Chem; 2001 Aug; 276(32):30359-65. PubMed ID: 11387313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.
    Gerber HP; McMurtrey A; Kowalski J; Yan M; Keyt BA; Dixit V; Ferrara N
    J Biol Chem; 1998 Nov; 273(46):30336-43. PubMed ID: 9804796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
    Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase.
    Avraham HK; Lee TH; Koh Y; Kim TA; Jiang S; Sussman M; Samarel AM; Avraham S
    J Biol Chem; 2003 Sep; 278(38):36661-8. PubMed ID: 12844492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells.
    Suzuma K; Naruse K; Suzuma I; Takahara N; Ueki K; Aiello LP; King GL
    J Biol Chem; 2000 Dec; 275(52):40725-31. PubMed ID: 11018037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.